Simó, Cristina http://orcid.org/0000-0002-5980-9379
Serra-Casablancas, Meritxell http://orcid.org/0000-0003-4806-3249
Hortelao, Ana C. http://orcid.org/0000-0001-9269-0480
Di Carlo, Valerio http://orcid.org/0000-0002-5099-0685
Guallar-Garrido, Sandra http://orcid.org/0000-0002-9666-5757
Plaza-García, Sandra
Rabanal, Rosa Maria http://orcid.org/0000-0002-9521-791X
Ramos-Cabrer, Pedro http://orcid.org/0000-0003-0368-7031
Yagüe, Balbino
Aguado, Laura
Bardia, Lídia
Tosi, Sébastien
Gómez-Vallejo, Vanessa http://orcid.org/0000-0003-3995-9596
Martín, Abraham
Patiño, Tania http://orcid.org/0000-0001-9979-7926
Julián, Esther http://orcid.org/0000-0002-6558-3978
Colombelli, Julien http://orcid.org/0000-0002-2784-4276
Llop, Jordi http://orcid.org/0000-0002-0821-9838
Sánchez, Samuel http://orcid.org/0000-0001-9713-9997
Article History
Received: 17 March 2023
Accepted: 20 November 2023
First Online: 15 January 2024
Competing interests
: S.S. is founder of the spin-off Nanobots Therapeutics S.L. J.L. is a member of the scientific advisory board of Starget Pharma and advisor to the spin-off Nanobots Therapeutics S.L. All other authors declare no competing interests.